Robert A. Ingram - General Partner @ Hatteras Venture Partners

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

252,926

Primary Job Title General Partner
Primary Organization
Hatteras Venture Partners

Location Durham, North Carolina, United States
Regions Research Triangle, East Coast, Southern US
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Bob Ingram is a General Partner at Hatteras Venture Partners and was a COO and President at GlaxoSmithKline. He attended Eastern Illinois University.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	PhaseBio Pharmaceuticals	Hatteras Venture Partners	No	Series C - PhaseBio Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	PhaseBio Pharmaceuticals	Hatteras Venture Partners	—	Series B - PhaseBio Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	PhaseBio Pharmaceuticals	Hatteras Venture Partners	—	Series B - PhaseBio Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	PhaseBio Pharmaceuticals	OSI Pharmaceuticals	Yes	Series B - PhaseBio Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	PhaseBio Pharmaceuticals	Hatteras Venture Partners	—	Venture Round - PhaseBio Pharmaceuticals	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Robert A. Ingram

has

current jobs including

Director

Wolfspeed

General Partner

Hatteras Venture Partners

, and

Member of the Board of Directors

HBM Healthcare Investments

. Additionally,

Robert A. Ingram

has had

past jobs including

Chairman of the Board of Director

OSI Pharmaceuticals

Wolfspeed DirectorDec 1, 2008
Hatteras Venture Partners General PartnerJan 24, 2007
HBM Healthcare Investments Member of the Board of Directors

Organization Name	Title At Company	Start Date	End Date
OSI Pharmaceuticals	Chairman of the Board of Director	2003	Jun 1, 2010
Nortel Networks	Director	—	—
GlaxoSmithKline	Chief Operating Officer and President	—	—
Allergan	Director	—	—
GlaxoWellcome	Chairman, President and Chief Executive Officer	—	—
GlaxoWellcome	CEO/Chairman	—	—
PPD clinical research business of Thermo Fisher Scientific	Director	—	—
Wolfspeed	Lead Independent Director	Oct 1, 2011	—
Wachovia Corporation	Director	—	—
GlaxoWellcome	Chief Executive Officer	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Robert A. Ingram

holds

board and advisor roles as

Board Member and member of the Nomination Committee

HBM Healthcare Investments

and

Chairman

Elan Corporation

HBM Healthcare Investments Board Member and member of the Nomination Committee
Elan Corporation Chairman

Organization Name	Title At Company	Start Date	End Date
PhaseBio Pharmaceuticals	Board of Director	—	Mar 5, 2018
OSI Pharmaceuticals	Chairman	—	—
Edwards Lifesciences	Board of Directors	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Investors Active in Research Triangle	14,033
Durham Investors	81,455
North Carolina Venture Stage Investors	94,923
Research Triangle Venture Capital Investors	86,186
Early Stage Venture Investors with Investments in Research Triangle	26,887
East Coast Convertible Note Investors	49,874
Research Triangle Investors	62,614
Research Triangle Early Stage Venture Investors	89,838
Southern US Venture Stage Investors	32,276
Research Triangle Seed Stage Investors	85,817